7Coveney E C, Geraghty J G, Sherry F,et al. Clinical valued CEA and CA 15-3 in breast cancer management[ J]. Int J Biol Markers, 1995,10( 1 ) :35-41. 被引量：1
8Buffaz P D, Gauchez A S, Caravel J P, et al. Can tumor marker msays be a guide in the prescription of bone scan for breast and lung cancers[J] .Eur J Nucl Med,1999,26(l) :8-11. 被引量：1
9Francini G, Montagnani M, Petrioli R, et al. Comparison between CEA,TPA, CA 15-3 and hydmxyprollne, alkaline phosphatase, whole body retention of 99mTc MDP in the follow-up of bone metastases in breast cancer[J] .Int J Bid Markers, 1990,5(1):65-72. 被引量：1
10Marrogi A J, Munshi A, Merogi AJ, et al. Study of tumor infiltrating lymphocytes and transforming growth factor beta ad prognostic factors in breast carcinoma[J]. Int J Cancer, 1997,74 (5) :492-501. 被引量：1
